A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
Strike Out Infection
Terry Francona, APIC and Covidien are teaming up to raise infection prevention awareness.
COV (NYSE)
| Price: | $49.79 |
| Change: | (0.28) |
| Volume: | 1,470,157 |
Minimum 20 minute delay
-
5/16/2008 8:30:00 AM
Covidien Commences Registered Exchange Offer
HAMILTON, Bermuda--(BUSINESS WIRE)--May 16, 2008--Covidien Ltd. (NYSE: COV, BSX: COV) and Covidien International Finance S.A. ("CIFSA") today announced that they have commenced a registered exchange offer to exchange up to $250,000,000 of CIFSA's newly registered 5.150% Senior Notes due 2...
-
5/15/2008 8:31:00 AM
Covidien to Present at Citigroup Healthcare Conference
HAMILTON, Bermuda--(BUSINESS WIRE)--May 15, 2008--Covidien Ltd. (NYSE: COV, BSX: COV) will present at the Citigroup 2008 Global Healthcare Conference on Thursday, May 22, 2008. Timothy R. Wright, President, Pharmaceutical Products and Imaging Solutions, will represent the company in a ses...
-
5/14/2008 8:31:00 AM
Covidien Announces Acquisition of Specialty Injection Devices from Pinyons Medical Technology, Inc.
Handheld injectors expand contrast delivery systems portfolio
ST. LOUIS--(BUSINESS WIRE)--May 14, 2008--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that it has signed an agreement with Pinyons Medical Technology Inc., a priv...
-
5/13/2008 9:28:00 AM
Covidien Introduces AbsorbaTack(TM) 5mm Hernia Fixation Device Featuring Absorbable Tacks in Europe
Surgical Devices Global Business Unit Provides Comprehensive Solutions for Soft Tissue Repair
NORTH HAVEN, Conn.--(BUSINESS WIRE)--May 13, 2008--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the European introdu...